Bernard Coulie
CIK 1808895 · President and CEO · last filed 2026-04-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.03M
Companies
3
Total Filings
36
Lifetime Open-Market Net
-$13.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-05 | PLRX | Mixed | — | -$513.5K | EDGAR |
| 2022-12-21 | PLRX | Mixed | +34,539 | -$653.5K | EDGAR |
| 2022-09-14 | PLRX | Mixed | — | -$255.8K | EDGAR |
| 2022-07-13 | PLRX | Mixed | — | -$561.5K | EDGAR |
| 2022-06-16 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | PLRX | Grant (A) | — | $0 | EDGAR |
| 2021-07-01 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | PLRX | Sell (S) | −4,000 | -$132.1K | EDGAR |
| 2021-05-17 | PLRX | Sell (S) | −3,500 | -$100.2K | EDGAR |
| 2021-04-15 | PLRX | Mixed | +2,500 | -$93.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.